[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
G P ArutiunovN A KoziolovaM V BoldinaM M BatyushinA S AmetovAlexander G ArutyunovAndrey BelevskiyA M GorbachevaN Y GrigorievaG A DzhunusbekovaA M EsaianS V Mal'chikovaAshot M MkrtumyanIana A OrlovaMarina M PetrovaAndrey P RebrovD I RuzanovV V SalukhovHamayak SisakianV V SkibitskiiA B SugralievI V FominI S KhalimovA I ChesnikovaIgor ShaposhnikMarina V ShestakovaPublished in: Terapevticheskii arkhiv (2020)
The agreement of experts of the Eurasian Association of Therapists (EAT) discusses pathogenesis and treatment of COVID-19. Modern data on the characteristics of cardiovascular, kidney, respiratory damage in SARS-infected CoV-2 are presented. The tactics of managing patients initially having cardiovascular diseases, diabetes mellitus, chronic obstructive pulmonary disease, bronchial asthma, chronic kidney disease are discussed in detail. The article presents data on drug interaction of drugs.
Keyphrases
- sars cov
- end stage renal disease
- chronic kidney disease
- chronic obstructive pulmonary disease
- respiratory syndrome coronavirus
- peritoneal dialysis
- cardiovascular disease
- electronic health record
- coronavirus disease
- ejection fraction
- newly diagnosed
- big data
- prognostic factors
- patient reported
- machine learning
- air pollution
- patient reported outcomes
- replacement therapy
- cardiovascular events
- adipose tissue
- glycemic control
- deep learning
- metabolic syndrome
- weight loss
- combination therapy
- insulin resistance
- skeletal muscle